Clinical Trials
Clinical Trials
Aizon Launches GxP AI Bioreactor Application for the Pharma Industry to Scale Manufacturing & Quality
Aizon launches its Bioreactor Application, the pharma industry’s first predictive analysis and deep knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the “Smart Manufacturing” transformation that is accelerating across the Pharma and Biotech industry. Aizon...
Clinical Trials
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Rigel Pharmaceuticals, Inc. announced it has been awarded $16.5 million by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to support Rigel's ongoing Phase 3 clinical trial to evaluate...
Clinical Trials
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the...
Clinical Trials
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people’s health and well-being, announced it will begin a clinical trial in Spain to evaluate...
Clinical Trials
Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio
Intravacc, a world leader in translational research and development of vaccines, announced that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and manufactured for Provention Bio in less than 36 months, has entered into a first in...
Clinical Trials
Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India
Dr. Reddy’s Laboratories Ltd announced that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India.
The phase 3 study of Sputnik V will be...
Clinical Trials
NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI in the I-SPY COVID-19 Trial
NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical Trial Participation Agreement for the inclusion of ZYESAMI™ in the I-SPY COVID-19 Clinical Trial....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read